❌

Normal view

There are new articles available, click to refresh the page.
Before yesterdayMain stream

The Power of Science Advocacy: Promoting Knowledge and Progress

23 July 2024 at 06:09

Science advocacy plays a critical role in promoting scientific literacy, influencing policy, and fostering a culture that values and supports scientific research. By bridging the gap between scientists and the public, science advocates work to ensure that science remains a central part of decision-making processes at all levels of society. As an expert in Science and Education, I will explore the…

Source

Understanding Science Policy: Bridging Science and Society

16 July 2024 at 07:54

Science policy plays a pivotal role in shaping the relationship between scientific research and societal needs. It encompasses the guidelines, regulations, and initiatives that govern scientific research and its application. As an expert in Science and Education, I will elucidate the intricacies of science policy, its significance, and its impact on scientific progress and societal advancement.

Source

Navigating Science Grants: A Comprehensive Guide

9 July 2024 at 07:19

Science grants are essential resources for researchers, educators, and institutions looking to advance scientific knowledge and innovation. These grants provide the necessary funding to conduct research, develop educational programs, and support scientific endeavors. As an expert in Science and Education, I will guide you through the intricacies of science grants, their importance…

Source

Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme

By: Beth Mole
1 July 2024 at 18:16
Alzheimer’s scientist indicted for allegedly falsifying data in $16M scheme

Enlarge (credit: Getty | Pavlo Gonchar)

A federal grand jury has indicted an embattled Alzheimer's researcher for allegedly falsifying data to fraudulently obtain $16 million in federal research funding from the National Institutes of Health for the development of a controversial Alzheimer's drug and diagnostic test.

Hoau-Yan Wang, 67, a medical professor at the City University of New York, was a paid collaborator with the Austin, Texas-based pharmaceutical company Cassava Sciences. Wang's research and publications provided scientific underpinnings for Cassava's Alzheimer's treatment, Simufilam, which is now in Phase III trials.

Simufilam is a small-molecule drug that Cassava claims can restore the structure and function of a scaffolding protein in the brain of people with Alzheimer's, leading to slowed cognitive decline. But outside researchers have long expressed doubts and concerns about the research.

Read 7 remaining paragraphs | Comments

❌
❌